SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

Anthony L. Rostain, MD, MA

Speaker Affiliation
Anthony L. Rostain, MD, MA
Professor of Psychiatry and Pediatrics, University of Pennsylvania Perelman School of Medicine
Co-Director, Developmental Neuropsychiatry Program, The Childrenís Hospital of Philadelphia
Medical Director, Adult ADHD Treatment & Research Program PENN Behavioral Health

: ASRS Part 2 of 3: Using the ASRS in Practice
Activity/Course #:
: Free
Release/Start Date:
: Dec 11 2018
Expiration Date:
: Dec 10 2020
: Psychiatry
Target Audience:
: Primary Care Providers
: ADHD Dissemination Webcast
Estimated Time To Complete CME Activity:
: 0.5 Hour
: 0.5 AMA PRA Category I Credit(s)
Hardware/Software Requirements:

Take the 3 ASRS courses and you qualify to access the NEW DSM-5 Online Screener and 18 symptom checklist for your practice. ADHD in Adults will contact you.

Learn more at



In this webcast, Dr. Rostain describes the science behind the ASRS in practice.

This webcast was recorded live and is being used with the permission of the presenter.

Learning Objectives

At the conclusion of this activity, the learner will be able to:

  1. Use the ASRS screener to screen for adult ADHD in the practice office.
  2. Be able to score the screener and determine and positive vs negative screen.
  3. Conduct a complete diagnosis of ADHD following a positive screen.
  4. Train office personnel to administer and score a screen for adult ADHD

How To Obtain Your CME Certificate

  1. Register for the course at
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 60% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Creditsô. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure is provided below.

Dr. Rostain serves on the scientific advisory boards of Shire, Ironshore, and Arbor. He is a consultant for MLB, NFL, and SUNY Upstate. He is an author for Rutledge /Taylor Francis and St. Martin's Press.

In the past year, Dr. Faraone received income, potential income, travel expenses continuing education support and/or research support from Lundbeck, Rhodes, Arbor, KenPharm, Ironshore, Shire, Akili Interactive Labs, CogCubed, Alcobra, VAYA, Sunovion, Genomind and Neurolifesciences. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. In previous years, he received support from: Shire, Neurovance, Alcobra, Otsuka, McNeil, Janssen, Novartis, Pfizer and Eli Lilly. Dr. Faraone receives royalties from books published by Guilford Press: Straight Talk about Your Childís Mental Health, Oxford University Press: Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He is principal investigator of Dr. Faraone is supported by the K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway, the European Unionís Seventh Framework Programme for research; technological development and demonstration under grant agreement no 602805, the European Unionís Horizon 2020 research and innovation programme under grant agreement No 667302 and NIMH grants 5R01MH101519 and U01 MH109536-01.

Jonathan Marx, Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, CHCP, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an independent medial educational grant from Shire.